RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Propanc Biopharma Stock

Propanc Biopharma Equity 2024

Propanc Biopharma Equity

-3.78 M USD

Ticker

PPCB

ISIN

US74346N4043

WKN

A2QJDP

In 2024, Propanc Biopharma's equity was -3.78 M USD, a 24.98% increase from the -3.02 M USD equity in the previous year.

Propanc Biopharma Aktienanalyse

What does Propanc Biopharma do?

Propanc Biopharma Inc. is a biotechnology company focused on the treatment of cancer. It was founded in 2007 in Australia and is now headquartered in Delaware, USA. The company is listed on the Australian stock exchange and the OTC Pink market in the USA. Propanc Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Propanc Biopharma's Equity

Propanc Biopharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Propanc Biopharma's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Propanc Biopharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Propanc Biopharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Propanc Biopharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Propanc Biopharma stock

What is the equity of Propanc Biopharma this year?

Propanc Biopharma has equity of -3.78 M USD this year.

What was the equity of Propanc Biopharma compared to the previous year?

The equity of Propanc Biopharma has increased/decreased by 24.98% increased compared to the previous year.

What impact does a high equity have on investors of Propanc Biopharma?

A high equity is advantageous for investors of Propanc Biopharma as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Propanc Biopharma?

A low equity can be a risk for investors of Propanc Biopharma, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Propanc Biopharma affect the company?

An increase in equity of Propanc Biopharma can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Propanc Biopharma affect the company?

A reduction in equity of Propanc Biopharma can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Propanc Biopharma?

Some factors that can affect the equity of Propanc Biopharma include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Propanc Biopharma so important for investors?

The equity of Propanc Biopharma is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Propanc Biopharma take to change the equity?

To change equity, Propanc Biopharma can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Propanc Biopharma pay?

Over the past 12 months, Propanc Biopharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Propanc Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Propanc Biopharma?

The current dividend yield of Propanc Biopharma is .

When does Propanc Biopharma pay dividends?

Propanc Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Propanc Biopharma?

Propanc Biopharma paid dividends every year for the past 0 years.

What is the dividend of Propanc Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Propanc Biopharma located?

Propanc Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Propanc Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Propanc Biopharma from 11/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/22/2024.

When did Propanc Biopharma pay the last dividend?

The last dividend was paid out on 11/22/2024.

What was the dividend of Propanc Biopharma in the year 2023?

In the year 2023, Propanc Biopharma distributed 0 USD as dividends.

In which currency does Propanc Biopharma pay out the dividend?

The dividends of Propanc Biopharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Propanc Biopharma

Our stock analysis for Propanc Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Propanc Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.